A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids
- PMID: 19001682
A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids
Abstract
Background & objectives: Antibiotic resistant bacterial nosocomial infections are a leading problem in intensive care units (ICU). Present investigation was undertaken to know antibiotic resistance in Acinetobacter baumannii and some other pathogens obtained from clinical samples from ICU causing nosocomial infections. Special emphasis was given on plasmid mediated transferable antibiotic resistance in Acinetobacter.
Methods: The clinical specimens obtained from ICU, were investigated to study distribution of nosocomial pathogens (272) and their antibiotic resistance profile. Acinetobacter isolates were identified by API2ONE system. Antimicrobial resistance was studied with minimum inhibitory concentration (MIC) by double dilution agar plate method. The plasmid profile of 26 antibiotic resistant isolates of Acinetobacter was studied. Curing of R-plasmids was determined in three antibiotic resistant plasmid containing A. baumannii isolates. Plasmid transfer was studied by transformation.
Results: Major infections found in ICU were due to Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus pyogenes. The infection rate was maximum in urinary tract (44.4%) followed by wound infections (29.4%), pneumonia (10.7%) and bronchitis (7.4%). Acinetobacter isolates displayed high level of antibiotic resistance (up to 1024microg/ml) to most of antibiotics. More than 90 per cent isolates of Acinetobacter were resistant to a minimum of 23 antibiotics. Plasmid profile of Acinetobacter isolates showed presence of 1-4 plasmids. Ethidium bromide cured plasmids pUPI280, pUPI281, pUPI282 with curing efficiencies 20, 16 and 11 per cent respectively while acridine orange cured plasmids pUPI280, pUPI281 with curing efficiencies 7 and 18 per cent retrospectively. Transformation frequency of E. coli HB101 with pUPI281 was 4.3 x 10(4) transformants/microg plasmid DNA.
Interpretation & conclusions: A. baumannii was found to be associated with urinary tract infections, respiratory tract infections, septicaemia, bacteraemia, meningitis and wound infections. A. baumannii displayed higher resistance to more number of antibiotics than other nosocomial pathogens from ICU. Antibiotic sensitivity of A. baumannii cured isolates confirmed plasmid borne nature of antibiotic resistance markers. Transfer of antibiotic resistant plasmids from Acinetobacter to other nosocomial pathogens can create complications in the treatment of the patient. Therefore, it is very important to target Acinetobacter which is associated with nosocomial infections.
Similar articles
-
Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.J Assoc Physicians India. 2009 Sep;57:636, 638-40, 645. J Assoc Physicians India. 2009. PMID: 20214000
-
Multiple drug resistant carbapenemases producing Acinetobacter baumannii isolates harbours multiple R-plasmids.Indian J Med Res. 2014 Aug;140(2):262-70. Indian J Med Res. 2014. PMID: 25297360 Free PMC article.
-
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7. Int J Antimicrob Agents. 2006. PMID: 16464562
-
Treatment of Acinetobacter infections.Expert Opin Pharmacother. 2010 Apr;11(5):779-88. doi: 10.1517/14656561003596350. Expert Opin Pharmacother. 2010. PMID: 20210684 Review.
-
[Bacterial resistance and antimicrobial therapy in respiratory medicine and intensive care].Medicina (B Aires). 2001;61(5 Pt 1):603-13. Medicina (B Aires). 2001. PMID: 11721330 Review. Spanish.
Cited by
-
Variability in plasma concentration of cefotaxime in critically ill patients in an Intensive Care Unit of India and its pharmacodynamic outcome: A nonrandomized, prospective, open-label, analytical study.J Pharmacol Pharmacother. 2016 Jan-Mar;7(1):15-21. doi: 10.4103/0976-500X.179356. J Pharmacol Pharmacother. 2016. PMID: 27127389 Free PMC article.
-
Effect of a novel podophage AB7-IBB2 on Acinetobacter baumannii biofilm.Curr Microbiol. 2012 Jul;65(1):66-72. doi: 10.1007/s00284-012-0127-2. Epub 2012 Apr 26. Curr Microbiol. 2012. PMID: 22535475
-
Synthesis of silver nanoparticles using Dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents.Int J Nanomedicine. 2012;7:483-96. doi: 10.2147/IJN.S24793. Epub 2012 Feb 1. Int J Nanomedicine. 2012. PMID: 22334779 Free PMC article.
-
Clinical and antimicrobial profile of Acinetobacter spp.: An emerging nosocomial superbug.Adv Biomed Res. 2014 Jan 9;3:13. doi: 10.4103/2277-9175.124642. eCollection 2014. Adv Biomed Res. 2014. PMID: 24600597 Free PMC article.
-
Frequency of microorganisms isolated in patients with bacteremia in intensive care units in Colombia and their resistance profiles.Braz J Infect Dis. 2013 May-Jun;17(3):346-52. doi: 10.1016/j.bjid.2012.10.022. Epub 2013 May 14. Braz J Infect Dis. 2013. PMID: 23683574 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources